A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modeling
From MaRDI portal
Publication:6627181
DOI10.1002/SIM.8159zbMATH Open1546.62891WikidataQ92991918 ScholiaQ92991918MaRDI QIDQ6627181
Chi Zhang, Beibei Guo, Sha Cao, Y. Zang, Yan Han
Publication date: 29 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Bayesian methodhierarchical modelingclinical trialadaptive designbiomarkersubgroup treatment effectmolecularly targeted agentsmarker-stratified design
Cites Work
- Title not available (Why is that?)
- Bayesian phase I/II adaptively randomized oncology trials with combined drugs
- Determining the Effective Sample Size of a Parametric Prior
- The analysis of matched proportions
- Frequentist Performance of Bayesian Confidence Intervals for Comparing Proportions in 2 × 2 Contingency Tables
- Two-stage marker-stratified clinical trial design in the presence of biomarker misclassification
This page was built for publication: A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modeling
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6627181)
